| 摘要 |
<p>SUSTAINED ACTION PHARMACEUTICAL FORMULATION The invention relates to a sustained action pharmaceutical formulation for topical use containing isosorbide dinitrate, characterised in that it contains a) a liquid lipophilic solvent for isosorbide dinitrate and b) a liquid hydrophilic solvent for isosorbide dinitrate in a weight ratio of a:b of between about 0.8 and 0.2, preferably of between about 0.5 and about 0.3.</p> |
